- Research
- Open access
- Published:
Differential impact of ventricular-arterial coupling on left ventricular function in patients with acute myocardial infarction: a comparison between preserved and reduced ejection fraction
Journal of Cardiovascular Imaging volume 33, Article number: 2 (2025)
Abstract
Background
Ventricular-arterial coupling (VAC) plays a crucial role in the initiation and progression of heart failure in patients with coronary artery disease. The influence of VAC on left ventricular (LV) function may vary depending on LV systolic function. This study investigated the relationship between VAC and LV function in patients with acute myocardial infarction (AMI), stratified by ejection fraction (EF).
Methods
Echocardiographic indices of LV volumes, systolic function, and diastolic function were measured using standard techniques. Effective arterial elastance (EA) was calculated based on stroke volume derived from the LV outflow waveform. Effective LV end-systolic elastance was determined using the single-beat method. The central aortic pressure waveform was recorded via applanation tonometry. Characteristic impedance (Zc) of the aortic root was calculated using Fourier transformation of both aortic pressure and flow waveforms.
Results
A total of 85 patients (mean age, 58.5 ± 10.6 years) with AMI were enrolled. They were classified into two groups: those with reduced EF (< 50%, 27 patients) and those with preserved EF (≥ 50%, 58 PATIENTS). In the adjusted linear regression analysis, E’ velocity was significantly associated with VAC (β = –0.310, P = 0.008) in the preserved EF group but not in the reduced EF group. LV global longitudinal strain showed significant positive associations with VAC (β = 0.505, P < 0.001), EA index (β = 0.536, P < 0.001), and Zc (β = 0.344, P = 0.018) exclusively in the preserved EF group.
Conclusions
The distinct influence of EF status on the relationships between hemodynamic parameters and LV diastolic and systolic functions suggests a differential interplay between arterial and ventricular dynamics depending on LV systolic function.
Background
Patients with coronary artery disease (CAD) often exhibit increased arterial stiffness due to shared common risk factors and pathophysiologic mechanisms [1, 2]. This stiffened arterial system and aorta, along with the resulting elevated systolic blood pressure (SBP), increase left ventricular (LV) afterload and myocardial oxygen demand. Simultaneously, low diastolic blood pressure (DBP) reduces coronary perfusion pressure, exacerbating myocardial ischemia. Together, these factors contribute to LV dysfunction and may ultimately lead to heart failure (HF), particularly HF with preserved ejection fraction (HFpEF) in patients with CAD [2,3,4,5,6].
Aortic load, which determines LV afterload, consists of both steady and dynamic components. The steady component is primarily influenced by microvascular properties, such as peripheral vascular resistance. In contrast, the dynamic component is shaped by the properties of conduit arteries, including the characteristic impedance (Zc) of the proximal aorta, the magnitude and location of wave reflections on the incident wave, and total arterial compliance—all of which are associated with arterial stiffness [4, 5, 7].
Optimal coordination between LV and the aorta is essential for maintaining efficient cardiac mechanics. Ventricular-arterial coupling (VAC) describes this interaction and has been shown to influence LV work and efficiency [4, 8]. As such, VAC serves as a valuable tool for evaluating how changes in ventricular function or arterial characteristics affect overall cardiac performance, particularly in the initiation and progression of HF [4, 5]. However, directly assessing ventricular-arterial interplay is challenging because arterial load is expressed in the frequency domain, while LV systolic function is measured in the time domain. Consequently, elastance—which describes the relationship between changes in pressure and volume and shares a common unit—has frequently been used to approximate the VAC index, despite certain limitations. VAC is typically expressed as the ratio of effective arterial elastance (EA) to effective left ventricular elastance (ELV) [4, 8].
VAC influences both LV systolic and diastolic function, with differing interactions proposed for HF with reduced ejection fraction (HFrEF) and HFpEF [4]. Consequently, the impact of VAC on LV function may differ between patients with CAD and reduced or preserved EF, yet this remains an area of limited investigation. In this study, we explored the association between VAC and LV function in patients with acute myocardial infarction (AMI), stratified by ejection fraction (EF).
Methods
Study patients
Patients hospitalized for AMI who underwent successful coronary reperfusion and consented to participate in this research were enrolled sequentially from June 2020 to May 2021. Patients with significant valvular heart disease or without sinus rhythm were excluded. Participants were categorized into two groups based on their EF: preserved EF (≥ 50%) and reduced EF (< 50%).
Data on age, sex, height, weight, body surface area (BSA), estimated glomerular filtration rate (eGFR), and comorbidities such as hypertension, diabetes mellitus, or angina were collected from electronic medical records. Additionally, previous medical histories of myocardial infarction (MI), HF, or stroke, smoking status, type of AMI, modality of coronary reperfusion, culprit lesions identified via coronary angiography, and discharge medications were also obtained.
Transthoracic echocardiographic study
Transthoracic echocardiographic studies were performed using the Vivid E95 system (GE Medical) within 4 days of the index event. M-mode tracings were used to measure LV wall thickness, LV end-diastolic and end-systolic dimensions, and left atrial (LA) dimension. The LA end-systolic volume was calculated using the biplane disc method. The LV mass index was determined using the Devereux formula [9]. LV volumes during diastole and systole were assessed from apical four- and two-chamber views using the modified Simpson method, and LV EF was subsequently calculated.
Using pulsed and tissue Doppler echocardiographic imaging, standard diastolic filling parameters were measured from the apical four-chamber view. These included peak early-diastolic (E wave) and peak late-diastolic (A wave) transmitral flow velocities, the E/A ratio, early-diastolic (E’ wave), late-diastolic (A’ wave), and systolic (S’ wave) septal mitral annular velocities, as well as the E/E’ ratio. The time-velocity integral of left ventricular outflow tract (LVOT) flow, obtained via pulsed-wave Doppler echocardiography from the apical five-chamber view, was multiplied by the LVOT area, measured in the parasternal long-axis view, to calculate stroke volume (SV). Cardiac output (CO) was calculated as SV × heart rate/1,000 and indexed to BSA to derive the cardiac index (CI). The peak systolic velocity of tricuspid regurgitant flow, obtained from the continuous-wave Doppler image in the right ventricular inflow view, was used to estimate right ventricular systolic pressure (RVSP). Right atrial pressure was estimated based on the diameter of the inferior vena cava and its changes during respiration.
LV strain analysis was performed using vendor-provided software on two-dimensional speckle-tracking images from the apical two-, three-, and four-chamber views. The average LV global longitudinal strain (GLS) was then calculated.
Hemodynamic study
Hemodynamic data were collected in the supine position immediately after the transthoracic echocardiographic study. To account for variations in body size, all hemodynamic parameters were indexed to BSA [8]. Brachial blood pressure (BP) was measured using a digital sphygmomanometer (Microlife BP A100, Microlife AG). Brachial pulse pressure (PP) was calculated as the difference between brachial SBP and DBP. Mean brachial BP was calculated using the formula: brachial PP/3 + DBP. Systemic vascular resistance (SVR) was determined by multiplying the mean brachial BP by 80, dividing by CO, and indexing the result to BSA (SVR index, SVRI). Central aortic pressures were measured using pressure wave analysis (PWA) of the radial artery pressure waveform via applanation tonometry (SphygmoCor, AtCor). The radial pressure waveform was calibrated using brachial SBP and DBP. PWA provided measurements of central (proximal aortic) SBP, central DBP, central PP, central end-systolic pressure (ESP), aortic augmentation index adjusted to a heart rate of 75 beats per minute (AIx75), pressure–time index during systole (sPTI), and pressure–time index during systole diastole (dPTI). Total arterial compliance (TAC) was calculated using the following equation and indexed to BSA (TAC index, TACI): TAC = (dPTI × SV)/[(sPTI + dPTI) × (central ESP – central DBP)] [10, 11].
Measurements of VAC and its components
Brachial ESP was calculated as 0.9 times the brachial SBP. EA was determined by dividing ESP by SV and indexed to BSA as EA index (EAI). The single-beat method was employed to estimate ELV using a time-varying elastance curve and the ratio of the pre-ejection period to the total systolic period (tNd) [12,13,14]. The tNd was derived from pulsed-wave Doppler tracings of LVOT flow at the apical 5-chamber view as the ratio of the interval from the electrocardiogram (ECG) Q wave to flow onset to the interval from the ECG Q wave to end flow (Fig. 1A). ELV was then indexed to BSA as ELV index (ELVI). VAC was calculated as the ratio of EA to ELV.
Measurements of the tNd, aortic characteristic impedance, and reflection magnitude (RM). A The tNd, defined as the ratio of the pre-ejection periods (PEP) to the total systolic period (PEP + ejection time [ET]) during ventricular systole, was derived from the pulsed-wave Doppler tracing of left ventricular outflow tract (LVOT) flow at the apical five-chamber view. It was calculated as the ratio of the interval from the electrocardiogram (ECG) Q wave to flow onset, to the interval from the ECG Q wave to the end of flow. B Measurements of aortic characteristic impedance and RM. Digitized data from LVOT flow and aortic pressure were aligned to calculate characteristic impedance and RM
Measurements of aortic characteristic impedance and reflection magnitude
Aortic pressure-flow analysis was conducted using digitized LVOT flow data obtained from pulsed-wave Doppler echocardiography at the apical five-chamber view and aortic pressure derived from the radial artery waveform. The analysis was performed using custom-developed software programmed in LabVIEW (National Instruments).
The systolic ejection time was synchronized by aligning the rapid increase in the aortic pressure wave with the onset of LVOT flow, and the dicrotic notch in the aortic pressure with the conclusion of LVOT flow. After Fourier transformation, the modulus of the aortic pressure to LVOT flow in the frequency domain was used to compute the aortic input impedance (Zin). The average value of Zin's third through tenth harmonics was then used to calculate the aortic characteristic impedance (Zc). Reflection magnitude (RM) was then computed as the ratio of the backward pressure wave to the forward pressure wave after wave separation analysis (Fig. 1B).
Statistical analysis
Continuous variables are expressed as the median (interquartile range, IQR), while categorical variables are presented as counts (%). The Mann–Whitney U-test was employed to compare median values between patients with preserved EF and reduced EF, while the chi-square test was used to analyze categorical variables. Associations between hemodynamic data and E'velocity, E/E'ratio, and LV GLS were analyzed using correlation and linear regression methods. Statistical analyses were performed using IBM SPSS ver. 23 (IBM Corp), and a P-value of < 0.05 was considered statistically significant.
Results
A total of 90 patients with AMI were enrolled sequentially. After excluding 5 patients with severe aortic stenosis, 85 participants remained in the study. Of these, 27 patients with reduced EF were categorized into the reduced EF group, while the remaining 58 were assigned to the preserved EF group.
Baseline clinical characteristics
Age, sex, height, body mass index, BSA, comorbidities including hypertension, diabetes mellitus, and angina, prior medical history of MI, HF, or stroke, current smoking status, initial Killip class, and eGFR showed no significant differences between patients with reduced EF and those with preserved EF. The percentage of patients with ST-elevation MI was higher in the reduced EF group compared to the preserved EF group. Except for one patient in the preserved EF group who underwent only percutaneous balloon angioplasty, all patients received percutaneous coronary stent placement for coronary reperfusion. Compared to the preserved EF group, the reduced EF group had a higher proportion of culprit lesions in the left anterior descending artery. Medications at discharge, including antiplatelet agents, beta-blockers, renin-angiotensin system inhibitors, calcium channel blockers, nitrates, and statins, were administered similarly across both groups (Table 1).
Comparison of echocardiographic and hemodynamic data
LV wall thickness, LV end-diastolic dimensions, LV mass index, LA dimension, and LA end-systolic volume index did not differ significantly between the preserved EF and reduced EF groups. However, the reduced EF group showed greater LV end-systolic dimensions, end-diastolic volume, end-systolic volume, and LV GLS, along with lower relative wall thickness, SV, CO, CI, and EF. E’ velocity, S’ velocity, and A velocity were significantly lower in the reduced EF group, while other LV diastolic parameters, including E/E’ ratio and RVSP, were comparable between the two groups (Table 2).
Brachial and central PP was significantly lower in the reduced EF group. However, brachial and central BP, SVRI, TACI, and AIx75 did not differ significantly between the groups. Similarly, ELVI showed no significant differences. EAI were significantly higher in the reduced EF group (median, 1.15 mmHg/mL∙m2 [IQR, 0.90–1.37 mmHg/mL∙m2] vs. median, 1.00 mmHg/mL∙m2 [IQR, 0.76–1.16 mmHg/mL∙m2], P = 0.039), contributing to an increased VAC (median, 1.13 [IQR, 1.01–1.30] vs. median, 0.97 [IQR, 0.85–1.20], P = 0.003). There were no significant differences in Zc or RM between the groups (Table 3).
Associations of E’ velocity and LV GLS with hemodynamic data
A distinct pattern of association between E’ velocity and hemodynamic parameters was observed based on EF status. In the preserved EF group, E’ velocity demonstrated a significant negative correlation with EAI, VAC, and Zc, and after adjusting for age, sex, and height in linear regression analysis, E’ velocity remained significantly associated only with VAC (β = –0.310, P = 0.008) (Fig. 2A), whereas no significant associations were observed with EAI or Zc (Tables 4, 5). In contrast, no significant correlation was found between E’ velocity and VAC in the reduced EF group (Fig. 2B). Although a correlation between E’ velocity and ELVI was identified in the reduced EF group, this association did not remain significant after adjustment in the linear regression analysis. Furthermore, no significant associations were observed between E’ velocity and SVRI, TACI, ELVI, or RM in either group after adjusted linear regression analysis (Table 5).
Correlations of ventricular-arterial coupling (VAC) with E’ velocity and left ventricular (LV) global longitudinal strain (GLS) stratified by ejection fraction (EF). The relationship between VAC and E’ velocity in patients with (A) EF ≥ 50% and (B) EF < 50%. The relationship between VAC and LV GLS in patients with (C) EF ≥ 50% and (D) EF < 50%
The E/E’ ratio, although correlated with VAC in the reduced EF group, did not show any significant associations with hemodynamic parameters in both groups after adjusted linear regression analysis.
Similarly, a distinct pattern of association between LV GLS and hemodynamic parameters emerged based on EF status. In the preserved EF group, LV GLS exhibited a significant positive correlation with VAC (Fig. 2C), SVRI (Fig. 3A), Zc (Fig. 3C), and EAI (Fig. 3E) as well as a significant negative correlation with TACI (Fig. 3G). After adjusting for age, sex, and height in linear regression analysis, LV GLS remained significantly associated with VAC (β = 0.505, P < 0.001), along with SVRI (β = 0.325, P = 0.026), EAI (β = 0.536, P < 0.001), Zc (β = 0.344, P = 0.018), and TACI (β = –0.290, P = 0.037) (Tables 4, 5). However, in the reduced EF group, no significant associations between LV GLS and hemodynamic parameters were observed in this group (Fig. 2D, 3B, 3D, 3 F, 3H), except for a positive correlation with RM (β = 0.545, P = 0.009).
Correlations of hemodynamic parameters with left ventricular (LV) global longitudinal strain (GLS) stratified by ejection fraction (EF). The relationship between systemic vascular resistance index (SVRI) and LV GLS in patients with (A) EF ≥ 50% and (B) EF < 50%. The relationship between characteristic impedance (Zc) and LV GLS in patients with (C) EF ≥ 50% and (D) EF < 50%. The relationship between effective arterial elastance index (EAI) and LV GLS in patients with (E) EF ≥ 50% and (F) EF < 50%. The relationship between total arterial compliance index (TACI) and LV GLS in patients with (G) EF ≥ 50% and (H) EF < 50%
Discussions
The main findings of this study indicate that VAC was significantly associated with E’ velocity and LV GLS in AMI patients with preserved EF, whereas no such association was observed in those with reduced EF. Furthermore, steady and dynamic aortic loads were found to correlate with LV GLS exclusively in AMI patients with preserved EF. These results underscore the distinct influence of EF status on the relationships between hemodynamic parameters and LV diastolic and systolic functions, as represented by E’ velocity and LV GLS, suggesting a differential interplay between arterial and ventricular dynamics in patients with preserved versus reduced EF.
In patients with HFrEF, reduction in LV pump efficiency, LV elastance, and peripheral tissue perfusion trigger compensatory activation of the sympathetic nervous system and the renin-angiotensin system, leading to elevated intravascular volume and arterial pressure, which subsequently increase arterial elastance [4]. Consequently, VAC also rises. In contrast, while ventricular-arterial mismatch is recognized as a critical factor in the onset and progression of HFpEF [5], both LV stiffness and aortic stiffness increase without a corresponding change in VAC [4]. Aligning with these observations, this study demonstrated higher EAI and VAC in AMI patients with reduced EF compared to those with preserved EF.
The most commonly used noninvasive method to evaluate diastolic dysfunction is the measurement of E’ velocity at the mitral annulus [15, 16]. A reduced E’ velocity serves as a well-established marker for identifying LV diastolic dysfunction, even in its earliest stages. A previous study demonstrated a significant negative association between VAC and E’ velocity in women with hypertension [7]. In this study, we found that in AMI patients with preserved EF, VAC was negatively associated with E’ velocity, while aortic steady and dynamic components showed no significant correlation. These findings suggest that ventricular-arterial mismatch exerts a more critical influence in LV diastolic dysfunction than aortic load alone. Conversely, in AMI patients with reduced EF, neither aortic load nor VAC was associated with E’ velocity, indicating that VAC exerts minimal influence on LV diastolic function in the setting of impaired LV systolic function.
LV GLS, derived from speckle-tracking echocardiography, has been shown to detect subtle changes in myocardial longitudinal fibers caused by ischemia in patients with preserved EF [17, 18]. As a result, LV GLS serves as a more sensitive marker of LV systolic dysfunction [19] and has demonstrated prognostic significance, with LV GLS > –14% identified as a poor prognostic factor in AMI patients with preserved EF [20]. Furthermore, because EF is one of the parameters used to calculate ELV in this study, LV GLS was employed to investigate the relationship of LV systolic dysfunction with aortic elastance, LV elastance, and VAC. A significant positive correlation of VAC with LV GLS has been shown in women with hypertension in a previous study [7]. In this study, a significant positive association of LV GLS with SVRI, Zc, EAI, and VAC, as well as a significant negative association with TACI, was demonstrated in the preserved EF group, but not in the reduced EF group. These findings suggest that aortic load and ventricular-arterial mismatch may contribute to LV systolic dysfunction and the progression to HFrEF in patients with preserved EF. However, in patients with already reduced EF, the influence of aortic load and ventricular-arterial mismatch on LV systolic function appears to be minimal. These findings underscore the importance of measuring aortic load and VAC in AMI patients with preserved EF to help prevent progression to HFrEF. Since antihypertensive therapy in patients with hypertension has been shown to reduce arterial stiffness and improve VAC [21], our findings further suggest the need for stricter BP control in AMI patients with hypertension.
Augmentation index (AIx) has frequently been used to assess the contribution of the reflected wave on central systolic pressure and PP in a stiff arterial system [22]. However, AIx has been shown to be influenced by factors such as heart rate, an individual’s height, and the location of the reflected wave, rather than just its amplitude [3]. As a result, its usefulness as a predictive factor for clinical events is limited. Another index of arterial stiffness, RM, has been proposed as a more accurate and novel measure for assessing pulsatile aortic afterload on LV function, and its predictive role in HF within the general population has also been demonstrated [23, 24], although it requires complex separation of incident and reflected waves from both flow and pressure waveforms. In this study, a significant positive correlation between RM and LV GLS was observed only in the reduced EF group, suggesting a potential role for RM as an exacerbating factor in LV systolic function in AMI patients with reduced EF.
This study has several limitations. First, as a cross-sectional study analyzing the relationship between hemodynamic parameters and LV functional parameters, this research cannot establish a direct causal effect of VAC and aortic load on LV diastolic and systolic functions. Furthermore, the study only included patients in the acute stage of MI, and the impact of VAC and aortic load on LV function may differ in the chronic stage. Therefore, the findings of this study should be interpreted with caution. These limitations underscore the need for a prospective study to confirm causality and to evaluate the effect of VAC and aortic load on LV function during the chronic stage of MI. Second, while noninvasive, transfer-function-based estimation of central aortic pressure from radial artery applanation tonometry is commonly used in clinical practice, it may not always accurately capture the central aortic pressure waveform due to inherent limitations of the technique [25]. Third, patients were on medications that could influence hemodynamic parameters. However, these medications were equally distributed between the preserved and reduced EF groups. Fourth, because body size can significantly affect hemodynamic parameters, these were indexed by BSA, and height was used as an adjusting factor in the regression analysis. However, this adjustment may not fully account for the effect of body size on the association between hemodynamic parameters and LV functional parameters. Fifth, LV diastolic function was evaluated using only septal E’ velocity, which may be influenced by regional wall motion abnormalities in the basal septal myocardium. This limitation particularly could affect the relationship between E’ velocity and hemodynamic parameters especially in AMI patients with reduced EF. Sixth, this study included only AMI patients. Therefore, the influence of EF status on the relationships between hemodynamic parameters and LV diastolic and systolic function needs to be evaluated in patients with HFpEF and HFrEF due to causes other than AMI.
Conclusions
VAC was significantly associated with E’ velocity and LV GLS in AMI patients with preserved EF, whereas no such associations were observed in those with reduced EF. Furthermore, steady and dynamic aortic loads correlated with LV GLS exclusively in AMI patients with preserved EF. These findings highlight the distinct influence of EF status on the relationships between hemodynamic parameters and LV diastolic and systolic functions, suggesting a differential interplay between arterial and ventricular dynamics depending on LV systolic function.
Data availability
The data underlying this article will be shared on reasonable request to the corresponding author.
Abbreviations
- Aix:
-
Augmentation index
- AIx75:
-
Augmentation index adjusted to a heart rate of 75 beats per minute
- AMI:
-
Acute myocardial infarction
- BP:
-
Blood pressure
- BSA:
-
Body surface area
- CAD:
-
Coronary artery disease
- CI:
-
Cardiac index
- COL:
-
Cardiac output
- DBP:
-
Diastolic blood pressure
- dPTI:
-
Pressure–time indexes during diastole
- EA :
-
Effective arterial elastance
- EAI:
-
Effective arterial elastance index
- ECG:
-
Electrocardiogram
- EF:
-
Ejection fraction
- eGFR:
-
Estimated glomerular filtration rate
- ELV :
-
Effective left ventricular elastance
- ELVI:
-
Effective left ventricular elastance index
- ESP:
-
End-systolic pressure
- GLS:
-
Global longitudinal strain
- HF:
-
Heart failure
- HFpEF:
-
Heart failure with preserved ejection fraction
- HFrEF:
-
Heart failure with reduced ejection fraction
- IQR:
-
Interquartile range
- LA:
-
Left atrial
- LV:
-
Left ventricular
- LVOT:
-
Left ventricular outflow tract
- MI:
-
Myocardial infarction
- PP:
-
Pulse pressure
- PWA:
-
Pressure wave analysis
- RM:
-
Reflection magnitude
- RVSP:
-
Right ventricular systolic pressure
- SBP:
-
Systolic blood pressure
- sPTI:
-
Pressure–time indexes during systole
- SV:
-
Stroke volume
- SVR:
-
Systemic vascular resistance
- SVRI:
-
Systemic vascular resistance index
- TAC:
-
Total arterial compliance
- TACI:
-
Total arterial compliance index
- tNd:
-
Ratio of the pre-ejection period to the total systolic period
- VAC:
-
Ventricular-arterial coupling
- Zc:
-
Characteristic impedance
- Zin:
-
Input impedance
References
Moon SH, Moon JC, Heo DH, Lim YH, Choi JH, Kim SY, et al. Increased pulse wave velocity and augmentation index after isometric handgrip exercise in patients with coronary artery disease. Clin Hypertens. 2015;21:5.
Lee JG, Joo SJ. Arterial stiffness and cardiovascular risk. Korean J Intern Med. 2019;34:504–6.
Vlachopoulos C, Xaplanteris P, Aboyans V, Brodmann M, Cífková R, Cosentino F, et al. The role of vascular biomarkers for primary and secondary prevention: a position paper from the European Society of Cardiology Working Group on peripheral circulation: endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015;241:507–32.
Ikonomidis I, Aboyans V, Blacher J, Brodmann M, Brutsaert DL, Chirinos JA, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions: a consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail. 2019;21:402–24.
Weber T, Chirinos JA. Pulsatile arterial haemodynamics in heart failure. Eur Heart J. 2018;39:3847–54.
Yoon HM, Joo SJ, Boo KY, Lee JG, Choi JH, Kim SY, et al. Impact of cardiac rehabilitation on ventricular-arterial coupling and left ventricular function in patients with acute myocardial infarction. PLoS ONE. 2024;19: e0300578.
Joo SJ, Boo KY, Lee JG, Choi JH, Kim SY. Sex differences in the impact of ventricular-arterial coupling on left ventricular function in patients with hypertension. PLoS ONE. 2024;19: e0313677.
Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol. 1985;2008(105):1342–51.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.
Liu Z, Brin KP, Yin FC. Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol. 1986;251(3 Pt 2):H588-600.
Russo C, Jin Z, Palmieri V, Homma S, Rundek T, Elkind MS, et al. Arterial stiffness and wave reflection: sex differences and relationship with left ventricular diastolic function. Hypertension. 2012;60:362–8.
Senzaki H, Chen CH, Kass DA. Single-beat estimation of end-systolic pressure-volume relation in humans: a new method with the potential for noninvasive application. Circulation. 1996;94:2497–506.
Shishido T, Hayashi K, Shigemi K, Sato T, Sugimachi M, Sunagawa K. Single-beat estimation of end-systolic elastance using bilinearly approximated time-varying elastance curve. Circulation. 2000;102:1983–9.
Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol. 2001;38:2028–34.
Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30:474–80.
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277–314.
Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37:1196–207.
Ruppert M, Lakatos BK, Braun S, Tokodi M, Karime C, Oláh A, et al. Longitudinal strain reflects ventriculoarterial coupling rather than mere contractility in rat models of hemodynamic overload-induced heart failure. J Am Soc Echocardiogr. 2020;33:1264–75.
Cameli M. Echocardiography strain: why is it used more and more? Eur Heart J Suppl. 2022;24(Suppl I):I38-42.
Ersbøll M, Valeur N, Mogensen UM, Andersen MJ, Møller JE, Velazquez EJ, et al. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013;61:2365–73.
Lam CS, Shah AM, Borlaug BA, Cheng S, Verma A, Izzo J, et al. Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency. Eur Heart J. 2013;34:676–83.
Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol. 2005;18:388–96.
Chirinos JA, Kips JG, Jacobs DR Jr, Brumback L, Duprez DA, Kronmal R, et al. Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol. 2012;60:2170–7.
Zamani P, Lilly SM, Segers P, Jacobs DR Jr, Bluemke DA, Duprez DA, et al. Pulsatile load components, resistive load and incident heart failure: the Multi-Ethnic Study of Atherosclerosis (MESA). J Card Fail. 2016;22:988–95.
Butlin M, Qasem A. Large artery stiffness assessment using SphygmoCor technology. Pulse (Basel). 2017;4:180–92.
Acknowledgements
Not applicable
Funding
None.
Author information
Authors and Affiliations
Contributions
Conceptualization: H Yun, S Joo Data curation: H Yun, S Joo Formal analysis: H Yun, S Joo Investigation: H Yun, S Joo, G Ko, K Boo, J Lee, J Choi, S Kim Methodology: H Yun, S Joo, J Choi. Project administration: S Joo. Resources: S Joo. Software: J Choi. Supervision: S Joo Validation: S Joo, K Boo, J Lee, J Choi, S Kim Visualization: H Yun, S Joo Writing – original draft: H Yun, S Joo Writing – review & editing: H Yun, S Joo, G Ko, K Boo, J Lee, J Choi, S Kim.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study protocol was approved by the Institutional Review Board of Jeju National University Hospital (No. JNUH- 2020–04 - 011). Written informed consent was obtained from all participating patients or their legal representatives. This study adhered to the principles outlined in the Declaration of Helsinki.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yun, H.E., Joo, SJ., Ko, G. et al. Differential impact of ventricular-arterial coupling on left ventricular function in patients with acute myocardial infarction: a comparison between preserved and reduced ejection fraction. J Cardiovasc Imaging 33, 2 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s44348-025-00045-6
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s44348-025-00045-6